Trial news

Asian MS: OCTOPUS and diversity in clinical trials webinar

We have now reached 245 participants randomised and 303 participants screened meaning we have recruited 65% of our goal for analysis stage 1 (375)!

So far:

• 13 hospital sites are open and actively contacting potential participants.
• 413 potential participants have been through telephone screening by their chosen site.
• 296 have attended their chosen hospital site for further screening and to give consent.
• 241 participants have entered the Octopus trial and started trial treatment.
• Another 134 participants will start treatment on the Octopus trial by December 2024 – to reach the goal of 375 participants in this first stage of the trial.

  We have now reached 228 participants randomised and 283 participants screened. This means we are 22 participants away from hitting 2/3 of our target for analysis stage 1 (375)! Check out the table below to see how each site is doing as of 16-May-2024: Site Number Screened Number Randomised UCLH (London) 108 93 University Hospital Southampton (Southamp ...

Read this short news update on how the Octopus trial team and MS Society have partnered up to work on programmes to consider ways we can increase diversity in clinical trials.